Mayo, good luck tomorrow. Please ask the tough questions and don't succumb to the company asking you to feed them softballs like the other 2 analysts. I've had enough of BS conf calls because the company cannot attract top tier analysts on the call. So we are stuck with the guy who can't take the phone off mute and when he figures that out he stumbles out a non relevant question. You on the other hand have an opportunity to hold their feet to the fire. We need distinct information on the path forward for the EMA, where we truly stand with a partner and what the FDA is doing with us. Personally I think if Missling goes about this the same way he has in the past, it will be very bad and I see us going into the $2 range. Maybe back up the truck area and hope for the best but I believe we are in a desperate spot as a company. We need something big to happen. We do not have the cash to do a large 1K person trial in the USA unless he sold10M shares in the $10 range a few months ago. Even if he did that, it will take 2.5 - 3 years to get results and we will be dead in the water. That needs to come out as well.
Ask him about shareholder value he should be creating. Ask him why after producing the greatest results ever seen for Alzheimer's , that we are sitting close to a 11 year low. WHY DOESN"T WALL STREET BELIEVE HIM? Having a credible CEO is key to success. He has none.
The company needs strategic thinking people for Wall Street. Bump Missling to Chairman and bring in a top tier pharma President/CEO.
AI
Market Data 
Markets 
